Highlights
Profile claimed by owner
About
Novel Anti-cancer Drugs
Cavos Biotech is developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found across various and specific animals.
Harnessing the latest in data and genomics, the company uses high-resolution identification methods to uncover existing anti-cancer mechanisms and novel drug targets in order to revolutionize the way drug targets are discovered and identified.
Identity
| Name | caVos Biotherapeutics |
|---|---|
| Slug | cavos-biotherapeutics |
| Type / kind | startup |
| Source _id | DGcaQIi3x9kMI4C7Zex2klaZCsMgTuD1fEaQZC6YIvQgXzqwR6OBkY |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Jerusalem |
| HQ address | Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/78737148 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
genomicscancer-researchdrug-discoverypharmaceuticalsdrug-developmentcancer-therapy
Funding
| Total raised | $3.3M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}